Gregorio Bonsignore

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Endoplasmic Reticulum

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Gregorio Bonsignore, Simona Martinotti, Elia Ranzato
Wound Repair and Ca 2+ Signalling Interplay: The Role of Ca 2+ Channels in Skin. Cells 13 (6) (2024)
Gregorio Bonsignore, Simona Martinotti, Elia Ranzato
Wound Repair and Ca 2+ Signalling Interplay: The Role of Ca 2+ Channels in Skin. Cells 13 (6) (2024)
Gregorio Bonsignore, Simona Martinotti, Elia Ranzato
Wound Repair and Ca 2+ Signalling Interplay: The Role of Ca 2+ Channels in Skin. Cells 13 (6) (2024)
Gregorio Bonsignore, Simona Martinotti, Elia Ranzato
Endoplasmic Reticulum Stress and Cancer: Could Unfolded Protein Response Be a Druggable Target for Cancer Therapy? International journal of molecular sciences 24 (2) (2023)
Gregorio Bonsignore, Simona Martinotti, Elia Ranzato
Endoplasmic Reticulum Stress and Cancer: Could Unfolded Protein Response Be a Druggable Target for Cancer Therapy? International journal of molecular sciences 24 (2) (2023)
Gregorio Bonsignore, Simona Martinotti, Elia Ranzato
Endoplasmic Reticulum Stress and Cancer: Could Unfolded Protein Response Be a Druggable Target for Cancer Therapy? International journal of molecular sciences 24 (2) (2023)
Gregorio Bonsignore, Simona Martinotti, Elia Ranzato
Endoplasmic Reticulum Stress and Cancer: Could Unfolded Protein Response Be a Druggable Target for Cancer Therapy? International journal of molecular sciences 24 (2) (2023)
Irene Fiorilla, Simona Martinotti, Alberto Maria Todesco, Gregorio Bonsignore, Maria Cavaletto, Mauro Patrone, Elia Ranzato, Valentina Audrito
Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma. Cells 12 (16) (2023)
Elia Ranzato, Gregorio Bonsignore, Simona Martinotti
ER Stress Response and Induction of Apoptosis in Malignant Pleural Mesothelioma: The Achilles Heel Targeted by the Anticancer Ruthenium Drug BOLD-100. Cancers 14 (17) (2022)